Combined Use of the Adenosine A2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys

✍ Scribed by Tomoyuki Kanda; Michael J. Jackson; Lance A. Smith; Ronald K.B. Pearce; Joji Nakamura; Hiroshi Kase; Yoshihisa Kuwana; Peter Jenner

• Book ID: 115607221
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 123 KB
• Volume: 162
• Category: Article
• ISSN: 0014-4886
• DOI: 10.1006/exnr.2000.7350